Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy

Background: Breast cancer is the leading cause of cancer among women in India. Treatment with hormone therapy reduces recurrence. We undertook this cost-effectiveness study to ascertain the treatment option offering the best value for money. Methods: The lifetime costs and health outcomes of using t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Breast cancer targets and therapy 2021-11, Vol.13, p.625
Hauptverfasser:	Prinja, Shankar, Gupta, Nidhi, Jyani, Gaurav, Bahuguna, Pankaj, Kapoor, Rakesh, Butani, Dimple
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Breast cancer Cancer Development and progression Economic aspects Health aspects Hormones Markov processes Medical care, Cost of Postmenopausal women Tamoxifen
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!